Indiana’s toxicology department sees more cases but shorter turnarounds amid staff shakeups
The Indiana State Department of Toxicology saw an all-time high number of cases submitted for blood analysis in 2025.
Read MoreThe Indiana State Department of Toxicology saw an all-time high number of cases submitted for blood analysis in 2025.
Read MoreThe facility will be responsible for global distribution of medical devices and will also accommodate light manufacturing.
Read MoreThe company, which is owned by biopharmaceutical giant Bristol Myers Squibb Co., is working on an incentive package with Whitestown officials that includes tax abatements for construction and new equipment for two buildings.
Bothell, Washington-based BioLife Solutions Inc. plans to move its manufacturing and research operations from Indianapolis to Hamilton County.
The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world,” officials said.
Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning.
Low founded seven companies based on intellectual property developed at Purdue, including Endocyte Inc., which he sold to Novartis Inc. in 2018 for $2.1 billion.
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
BiomEdit CEO Aaron Schacht talks about the strategy behind the round and the changes the animal health startup had to make to secure the money it needed to bring its first product to market,
The animal health startup had fundraising success in 2025, a year in which investment deals were hard to come by.
The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline of genetic medicines.
Ventyx is a San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis.
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Lewis sat down with IBJ to talk about his leadership style and the role of cycling in his life.
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
The Bloomington-based Applied Research Institute, which manages Heartland BioWorks, said the agreement will position Indiana as a “central nexus for biomanufacturing training and innovation.”
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
The move continues the Indianapolis-based drugmaker’s investments in age-related diseases.
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.